Joy Wang

Joy (Haiying) Wang is an accomplished business development and corporate strategy executive with significant experience in the pharmaceutical and biotechnology sectors. Currently serving as Vice President of Business Development and Corporate Strategy at Dendreon, Joy previously held leadership roles at Baxter International Inc. as Senior Director and Head of Global BD&L, M&A, and at Novartis and Sandoz in business development positions. Joy also led the US office as BD&L Director at Simcere Pharmaceutical Group & BioScikin Venture Capital. Educational qualifications include a full-time MBA in Finance/Marketing from UCLA Anderson School of Management and a PhD in Biomedical Sciences from Texas A&M Health Science Center.